Cart summary

You have no items in your shopping cart.

BAY 11-7082

SKU: orb1307179

Description

BAY 11-7082 (also known as BAY 11-7821) is a cell-permeable small molecule that potently inhibits the deubiquitinases USP7 and USP21, and also suppresses NF-κB activation by blocking TNFα-induced IκBα phosphorylation. This dual activity makes it a valuable research tool for studying inflammatory signaling, immune regulation, and cancer pathways in both cellular and animal models.

Research Area

Cell Biology, Molecular Biology, Protein Biochemistry, Signal Transduction

Images & Validation

Key Properties

CAS Number19542-67-7
MW207.25
Purity99.92% (May vary between batches)
FormulaC10H9NO2S
SMILESCc1ccc(cc1)S(=O)(=O)\C=C\C#N
TargetAutophagy,IκB/IKK,DUB,NF-κB,Apoptosis
SolubilityEthanol:5.2 mg/mL (25.09 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.08 mg/mL (10.04 mM);DMSO:29.6 mg/mL (142.82 mM)

Bioactivity

Target IC50
IκBα phosphorylation:10 μM|IκBα phosphorylation:10 μM|USP21:0.96 μM|USP7:0.19 μM
In Vivo
METHODS: To investigate the immunomodulatory effects, BAY 11-7082 (5-10 mg/kg) was injected intraperitoneally into C57BL/6 mice, followed 1 h later by intravenous injection of poly U (50 µg/head) + in vivo-jetPEI. RESULTS: Treatment with BAY 11-7082 inhibits the IFN response in vivo by limiting pDC function when stimulated with TLR ligands. METHODS: To investigate the effects on psoriasiform dermatitis, BAY 11-7082 (20 mg/kg) was injected intraperitoneally into C57BL/6 and NLRP3 KO mice with IMQ-induced psoriasiform lesions once daily for seven days. RESULTS: BAY 11-7082 blunted epidermal thickness, acanthosis and inflammatory infiltrates.BAY 11-7082 decreased the expression of pNF-κB, NLRP3, TNF-α, IL-6 and IL-1β, attenuated the phosphorylation of signal transducers and STAT3, and lowered IL-23 levels.
In Vitro
METHODS: Human colorectal cancer cells HT29 were treated with BAY 11-7082 (10-100 µM) for 1 h, followed by stimulation with TNF (50 ng/mL) for 3-10 min or Flag-TWEAK (200 ng/mL) for 8 h. The expression levels of target proteins were detected by Western Blot. RESULTS: Bay 11-7082 inhibited TWEAK-induced p100 processing and TNF-induced phosphorylation and degradation of IκBα. Both NFκB pathways were significantly blocked at concentrations of 30-100 µM of Bay 11-7082. METHODS: Macrophage RAW264.7 was treated with BAY 11-7082 (15 µM) and LPS (1 µg/mL) for 6 h, and TNF-α levels were measured by ELISA Assay. RESULTS: BAY 11-7082 blocked TNF-α production in LPS-treated RAW264.7 cells, which is an inflammatory response generated by activated NF-κB.
Cell Research
Cells are transfected with siRNA in 96-well microtiter plates and then cultured for 72 hours in complete NSCLC medium, treated with BAY 11-7082 for 12 hours. Cells are incubated with [3H]thymidine for 3 hours. The cells are collected on filters using an automatic cell harvester and radioactivity on the filters is measured by β-scintillation counting.(Only for Reference)

Storage & Handling

Storagestore at low temperature,keep away from direct sunlight,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ubiquitin, T-cell, phosphorylation, adhesion, Apoptosis, Autophagy, BAY 117082, BAY 11-7082, BAY 11-7821, BAY 11 7082, B-cell, cytokine, Deubiquitinase, DUBs, I kappa B kinase, leukaemic, IKK, IkB, IkB/IKK, E2-conjugating enzymes, Inhibitor, inhibit, IκBα phosphorylation, IκB, IκB kinase, inflammasome, lymphoma

Similar Products

  • Sodium Phenylbutyrate [orb1225948]

    >98% (HPLC)

    1716-12-7

    186.18

    C10H11NaO2

    50 mg, 200 mg, 1 g, 100 mg, 500 mg
  • Benzenebutyric acid [orb1220618]

    >98% (HPLC)

    1821-12-1

    164.2

    C10H12O2

    500 mg, 1 g
  • BAY 11-7082 [orb1225784]

    >98% (HPLC)

    19542-67-7

    207.249

    C10H9NO2S

    1 g, 25 mg, 500 mg, 50 mg, 200 mg, 5 mg, 100 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

J Guo, X Ma, L Wu, W Zhao, Y Zhang, C Hao, Y Yang, Z Yin, T Xu, Y Zhang, Y Guo, X Cao Inhibition of Nuclear factor kappa B ameliorates bone destruction and osteoclastogenesis in collagen-induced arthritis mice African Health Sciences, (2025)

BAY 11-7082 (orb1307179)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
$ 90.00
5 mg
$ 90.00
10 mg
$ 100.00
25 mg
$ 140.00
50 mg
$ 220.00
100 mg
$ 320.00
200 mg
$ 460.00
500 mg
$ 740.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry